Lexpos News

Pharmacy owners have just over a week left to start the Pharmacy Quality Scheme (PQS) Antimicrobial Stewardship – Pharmacy First consultations – Clinical Audit. The audit, which is a quality criterion in the Patient safety domain of the 2025/26 PQS, requires pharmacy owners to complete a clinical audit focused on the clinical advice and consultations provided to [...]

The post PQS: Have you started your AMS Pharmacy First audit? appeared first on Community Pharmacy England.

NHS England has tasked Integrated Care Boards (ICBs) to encourage primary care providers, including community pharmacies, to sign up to the NHS Sexual Safety Charter. All employers in the UK have a legal duty to take reasonable steps to prevent sexual harassment in the workplace. The sexual safety of staff and patients is an essential [...]

The post NHS’ Sexual Safety Charter appeared first on Community Pharmacy England.

Community pharmacies across the country have entered 2026 “in real economic peril” and urgently need a roadmap to recovery, Community Pharmacy England has warned the Government ahead of upcoming negotiations. In an uncompromising letter to Pharmacy Minister Stephen Kinnock, CEO Janet Morrison has outlined the sector’s escalating crisis and called on Government to deliver rapid [...]

The post CPE pushes Minister for roadmap to recovery ahead of make-or-break negotiations appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (23/01/2026) confirmed the following list of price concessions for January 2026: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.54 Aspirin 75mg gastro-resistant tablets 28 £1.00 Clomipramine 50mg capsules 28 £6.89 Cyclizine 50mg/1ml solution for injection ampoules 5 £3.59 Duloxetine 60mg gastro-resistant capsules 28 [...]

The post January 2026 Price Concessions 2nd Update appeared first on Community Pharmacy England.

The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare professionals to review these new measures and supporting materials and integrate them into their clinical practice. Second prescriber no longer required plus updated risk [...]

The post MHRA Drug Safety Update: Isotretinoin – changes to prescribing guidance and additional risk minimisation measures appeared first on Community Pharmacy England.